% ============================================================================
% CONSTRAINT STORY: neural_interface_standardization
% ============================================================================
% Version: 1.0 (Deferential Realism Core + Directionality + Boltzmann + Network)
% Logic: 6.0 (Indexed Tuple P,T,E,S + Sigmoid f(d) + Coupling + Purity + Network)
% Generated: 2026-02-26
% Status: [ACTIVE]
% ============================================================================

:- module(constraint_neural_interface_standardization, []).

:- use_module(constraint_indexing).
:- use_module(domain_priors).
:- use_module(narrative_ontology).

% --- Constraint Identity Rule (DP-001: ε-Invariance) ---
% Each constraint story must have a single, stable base extractiveness (ε).
% If changing the observable used to evaluate this constraint would change ε,
% you are looking at two distinct constraints. Write separate .pl files for
% each, link them with affects_constraint/2, and document the relationship
% in both files' narrative context sections.
%
% The context tuple is CLOSED at arity 4: (P, T, E, S).
% Do not add measurement_basis, beneficiary/victim, or any other arguments.
% Linter Rule 23 enforces context/4.
%
% See: epsilon_invariance_principle.md

% --- Namespace Hooks (Required for loading) ---
:- multifile
    domain_priors:base_extractiveness/2,
    domain_priors:suppression_score/2,
    domain_priors:theater_ratio/2,
    domain_priors:requires_active_enforcement/1,
    narrative_ontology:has_sunset_clause/1,
    narrative_ontology:interval/3,
    narrative_ontology:measurement/5,
    narrative_ontology:constraint_metric/3,
    narrative_ontology:constraint_beneficiary/2,
    narrative_ontology:constraint_victim/2,
    narrative_ontology:constraint_claim/2,
    narrative_ontology:affects_constraint/2,
    narrative_ontology:coordination_type/2,
    constraint_indexing:constraint_classification/3,
    constraint_indexing:directionality_override/3,
    narrative_ontology:omega_variable/3,
    narrative_ontology:human_readable/2,
    narrative_ontology:topic_domain/2.

/* ==========================================================================
   1. NARRATIVE CONTEXT
   ========================================================================== */

/**
 * CONSTRAINT IDENTIFICATION
 *   constraint_id: neural_interface_standardization
 *   human_readable: Neural Interface Standardization and Proprietary Lock-In
 *   domain: neurotechnology/medical_device_regulation
 *
 * SUMMARY:
 *   Neural interface standardization presents a critical tension in medical
 *   device regulation: the genuine need for rigorous safety standards and
 *   device compatibility intersects with incumbent manufacturers' ability to
 *   control standardization processes and extract economic rents from
 *   patients and competitors. The neural interface market is transitioning
 *   from a single-player monopoly (first-generation invasive devices) to
 *   multi-manufacturer competition, but standardization remains fragmented
 *   and proprietary. Early-adopter manufacturers have de facto
 *   standard-setting power through regulatory capture and network effects,
 *   while patients implanted with incompatible devices face surgical
 *   switching costs that lock them into single-manufacturer ecosystems. The
 *   constraint exhibits tangled rope structure: real coordination benefits
 *   (safety validation, clinical training protocols, software ecosystem
 *   development) coexist with substantial extraction mechanisms (proprietary
 *   lock-in, regulatory barriers to entry, patient switching costs). The
 *   measurement trajectory shows the constraint's extraction increasing over
 *   the interval as the installed base of locked-in patients grows,
 *   manufacturers consolidate capture of regulatory processes, and the
 *   theater ratio (clinical and regulatory performance of standardization
 *   efforts) climbs while real interoperability stalls. This is a constraint
 *   family that decomposes into three structurally distinct stories: (1)
 *   proprietary device firmware/software lock-in (ε≈0.65, Snare for
 *   patients), (2) regulatory standardization capture (ε≈0.48, Tangled Rope
 *   for competing manufacturers), and (3) data protocol interoperability
 *   (ε≈0.35, Rope with real coordination burden). We generate the
 *   family-level story that integrates across all three.
 *
 * KEY AGENTS:
 *   - Early Adopter Manufacturers (institutional/arbitrage): Beneficiaries — establish de facto standards, capture network effects, extract licensing rents; experience constraint as coordination problem they are solving
 *   - Implanted Patients (powerless/trapped): Primary victims — locked into incompatible device ecosystems, face surgical switching costs, bear full extraction burden with no coordination benefit
 *   - Competing Manufacturers (moderate/constrained): Secondary victims — face regulatory barriers to entry, must validate against proprietary standards, excluded from established patient populations but can exit at high cost
 *   - Regulatory Agencies (institutional/constrained): Captured beneficiaries — accept incumbent standards to accelerate approval, reduce liability; become partially dependent on manufacturer technical expertise
 *   - Standardization Bodies ISO/IEEE (organized/constrained): Attempting to break lock-in — developing open neural interface standards but progress is slow (5-10 years); have organized power but limited enforcement mechanism
 *   - Legacy Device Patients (powerless/trapped): Structurally similar to current patients but even more severely trapped — devices no longer supported by manufacturers, standards frameworks are theatrical, no upgrade pathway
 *   - Analytical Observer (analytical/analytical): Risks naturalizing contingent policy failures as inherent biological complexity
 */

/* ==========================================================================
   2. BASE PROPERTIES (DOMAIN PRIORS)
   ========================================================================== */

% --- Numerical metrics ---
domain_priors:base_extractiveness(neural_interface_standardization, 0.58).
domain_priors:suppression_score(neural_interface_standardization, 0.62).
domain_priors:theater_ratio(neural_interface_standardization, 0.55).

% --- Constraint metric facts (engine primary keys, must mirror domain_priors) ---
narrative_ontology:constraint_metric(neural_interface_standardization, extractiveness, 0.58).
narrative_ontology:constraint_metric(neural_interface_standardization, suppression_requirement, 0.62).
narrative_ontology:constraint_metric(neural_interface_standardization, theater_ratio, 0.55).

% --- Constraint claim ---
narrative_ontology:constraint_claim(neural_interface_standardization, tangled_rope).
narrative_ontology:human_readable(neural_interface_standardization, "Neural Interface Standardization and Proprietary Lock-In").
narrative_ontology:topic_domain(neural_interface_standardization, "neurotechnology/medical_device_regulation").

domain_priors:requires_active_enforcement(neural_interface_standardization).

% --- Structural relationships ---
narrative_ontology:constraint_beneficiary(neural_interface_standardization, early_adopter_manufacturers).
narrative_ontology:constraint_beneficiary(neural_interface_standardization, regulatory_agencies_captured).
narrative_ontology:constraint_victim(neural_interface_standardization, patient_switching_costs).
narrative_ontology:constraint_victim(neural_interface_standardization, competing_manufacturers).
narrative_ontology:constraint_victim(neural_interface_standardization, device_interoperability).

/* ==========================================================================
   3. INDEXED CLASSIFICATIONS (P, T, E, S)
   ========================================================================== */

% PERSPECTIVE 1: IMPLANTED PATIENT (SNARE) — Once a neural interface is implanted, the patient is structurally trapped. Switching to a competing device requires neurosurgery with non-negligible morbidity risk, retraining on new protocols, and potential loss of years of neural adaptation. The patient bears full extraction cost: high switching costs, limited device choice, proprietary software dependencies, manufacturer-controlled firmware updates. No coordination benefit reaches the patient — the standardization constraint serves manufacturers, not patient safety.
constraint_indexing:constraint_classification(neural_interface_standardization, snare,
    context(agent_power(powerless),
            time_horizon(biographical),
            exit_options(trapped),
            spatial_scope(global))).

% PERSPECTIVE 2: COMPETING MANUFACTURER (TANGLED ROPE) — New entrants face genuine coordination costs: they must validate devices against proprietary standards set by incumbent manufacturers, navigate regulatory approval that references first-mover design specs, and build ecosystem support (software, clinical training, aftermarket services). They also bear extraction: lock-in standards exclude them from established patient populations. But they can exit at high cost (relocating to alternative healthcare markets, investing in proprietary ecosystems). Mixed extraction and coordination burden.
constraint_indexing:constraint_classification(neural_interface_standardization, tangled_rope,
    context(agent_power(moderate),
            time_horizon(biographical),
            exit_options(constrained),
            spatial_scope(national))).

% PERSPECTIVE 3: EARLY ADOPTER MANUFACTURER (ROPE) — Experiences the constraint as pure coordination: their de facto standard becomes the reference point for regulatory approval, clinical practice, and patient expectations. They capture network effects (more patients on their device = more software developers, more clinical knowledge, more regulatory favorable treatment). They have arbitrage exit: can leverage their standard-setting position in one market into another, can license their standard to others and extract licensing rents. Benefits flow toward them; they perceive the constraint as solving genuine safety coordination problems.
constraint_indexing:constraint_classification(neural_interface_standardization, rope,
    context(agent_power(institutional),
            time_horizon(immediate),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 4: REGULATORY AGENCY (TANGLED ROPE) — Faces genuine coordination problem: neural interfaces are high-risk devices requiring validated safety standards, and creating standards from scratch is expensive and slow. Accepting the incumbent manufacturer's de facto standard dramatically accelerates approval and reduces agency liability risk. But the agency becomes partially captured: it references incumbent specs in approval frameworks, making competitors appear 'non-standard' even when equivalently safe. The agency experiences both coordination benefit (faster, safer approvals) and subtle extraction (loses independent standard-setting authority; incumbent manufacturers gain regulatory voice).
constraint_indexing:constraint_classification(neural_interface_standardization, tangled_rope,
    context(agent_power(institutional),
            time_horizon(biographical),
            exit_options(constrained),
            spatial_scope(national))).

% PERSPECTIVE 5: STANDARDIZATION BODY (SCAFFOLD) — International bodies (ISO, IEEE) are working to create genuinely open standards for neural interface interoperability, biocompatibility, and safety validation. These efforts have a sunset clause: successful open standards would enable device switching, reduce lock-in extraction, and distribute coordination burden across manufacturers. The constraint persists because standardization is slow (5-10 years to publish mature standards) and incumbent manufacturers have regulatory capture advantage. But organized pressure (patient advocacy, regulators in non-captured jurisdictions) is pushing the process forward. This perspective sees the lock-in as a temporary coordination failure being actively solved.
constraint_indexing:constraint_classification(neural_interface_standardization, scaffold,
    context(agent_power(organized),
            time_horizon(generational),
            exit_options(constrained),
            spatial_scope(global))).

% PERSPECTIVE 6: LEGACY DEVICE ECOSYSTEM (PITON) — Many early neural interfaces are no longer actively supported by manufacturers (technology obsolescence, company acquisition, market retreat). Yet patients remain implanted on these deprecated devices, and the 'standardization framework' for supporting them is largely theatrical: regulatory compliance focused on legacy device documentation rather than genuine interoperability, clinical practice centered on individual device training rather than transferable protocols. The constraint persists through institutional inertia — the ecosystem is maintained because patients still use the devices, not because the standards actually work. Theater ratio is elevated by this deadweight of unsupported legacy devices.
constraint_indexing:constraint_classification(neural_interface_standardization, piton,
    context(agent_power(institutional),
            time_horizon(civilizational),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 7: ANALYTICAL OBSERVER / NATURAL LAW VIEW (MOUNTAIN) — From a neuroscience and biomedics perspective, some standardization lag is inherent to the neural interface domain: individual nervous systems vary substantially in electrode sensitivity, signal characteristics, adaptation kinetics, and biocompatibility responses. A 'universal standard' that works identically across all patients and anatomies is theoretically impossible — neural tissue is not silicon. This perspective views standardization variation as a natural consequence of biological complexity, not a contingent institutional arrangement. However, the structural data reveals this as a false summit: the lock-in extraction mechanism operates at the data protocol, software API, and regulatory compliance level — layers where genuine standardization is entirely feasible. The 'biological uniqueness' frame naturalizes what is actually a policy choice.
constraint_indexing:constraint_classification(neural_interface_standardization, mountain,
    context(agent_power(analytical),
            time_horizon(civilizational),
            exit_options(analytical),
            spatial_scope(universal))).

/* ==========================================================================
   4. VALIDATION TESTS
   ========================================================================== */

:- begin_tests(neural_interface_standardization_tests).

test(perspectival_gap) :-
    constraint_indexing:constraint_classification(neural_interface_standardization, TypePowerless, context(agent_power(powerless), _, _, _)),
    constraint_indexing:constraint_classification(neural_interface_standardization, TypeOther, context(agent_power(moderate), _, _, _)),
    TypePowerless \= TypeOther.

test(extraction_signature) :-
    domain_priors:base_extractiveness(neural_interface_standardization, E),
    E >= 0.46. % Ensures high-extraction Snare/Tangled territory.

test(piton_threshold) :-
    domain_priors:theater_ratio(neural_interface_standardization, TR),
    TR >= 0.70.

:- end_tests(neural_interface_standardization_tests).

/* ==========================================================================
   5. GENERATIVE COMMENTARY
   ========================================================================== */

/**
 * LOGIC RATIONALE:
 *   Extractiveness (0.58): The constraint exhibits substantial extraction but not maximum because genuine coordination benefits exist alongside lock-in mechanisms. Early-adopter manufacturers do invest in safety validation and ecosystem development — this is not pure predation. The measuring extractiveness at 0.58 reflects that roughly 60% of the constraint's structure serves extraction/lock-in while 40% provides real coordination value. The trajectory from 0.35 to 0.58 reflects the accumulation of lock-in extraction as the installed base of locked-in patients grows. Suppression (0.62): High. Multiple barriers exist to exiting the constraint: surgical switching costs (medical/physical barrier), regulatory approval delays (institutional barrier), proprietary software lock (technical barrier), and lack of clinician training on alternative devices (informational barrier). The trajectory from 0.50 to 0.62 reflects increasing regulatory entrenchment and patient switching cost accumulation. Theater ratio (0.55): Moderate-high. Regulatory approval processes reference 'neural interface safety standards' that are largely incumbent manufacturer specifications rather than independently validated standards. Clinical training frameworks emphasize device-specific protocols rather than transferable skills. Standardization bodies publish guidelines that lack enforcement mechanisms. The theater increases from 0.42 to 0.55 as regulatory and clinical institutions invest more effort in supporting the incumbent standard while alternatives remain underdeveloped.
 *
 * PERSPECTIVAL GAP:
 *   The perspectival gap between early-adopter manufacturer (Rope) and implanted patient (Snare) reveals the constraint's core structural inequality. The manufacturer's perception of 'solving safety coordination problems' and the patient's perception of 'being locked into incompatible ecosystem' are both accurate descriptions of the same structural mechanisms. A standardization framework that truly served coordination would: (1) establish safety validation criteria independent of any manufacturer's proprietary specs; (2) certify device interoperability at standardizable interfaces (data protocol, firmware API, software module boundaries); (3) ensure patient/clinician access to device-switching information and compatible alternatives. The current framework serves these functions partly (safety validation exists) but not fully (interoperability certification is weak, switching barriers are high). The gap between what manufacturers perceive as their coordination burden and what patients perceive as extractive lock-in is the target for reform.
 *
 * DIRECTIONALITY LOGIC:
 *   Directionality for each perspective is computed from the agent's structural relationship to extraction flows and exit capacity. Early-adopter manufacturers (institutional/arbitrage) derive d≈0.10 from beneficiary status + high exit options (can relocate standard to other markets, can license it, can shift to next-generation technology) — their experienced extraction is low/negative (they net benefit). Implanted patients (powerless/trapped) derive d≈0.95 from victim status + zero exit options (surgery is infeasible, no alternative ecosystems exist) — their experienced extraction is maximum. Competing manufacturers (moderate/constrained) derive d≈0.65 from victim status + moderate exit options (can relocate to alternative markets, can build proprietary ecosystems, but at high cost) — experienced extraction is substantial but not absolute. Regulatory agencies (institutional/constrained) derive d≈0.35 from partial beneficiary status (they solve a coordination problem) + constrained exit (they depend on manufacturer technical input, cannot easily switch standards) — experienced extraction is moderate toward the beneficiary end. Standardization bodies (organized/constrained) derive d≈0.50 from neutral position (neither primary beneficiary nor victim, but constrained by incumbent market power) — experienced extraction is balanced. The directionality spread (0.10 to 0.95) is the perspectival gap.
 *
 * MANDATROPHY ANALYSIS:
 *   MANDATROPHY RESOLUTION: The constraint at ε=0.58 requires mandatrophy resolution because the base extractiveness exceeds the tangled rope threshold (0.46). The resolution shows that the constraint IS genuinely tangled rope (not pure snare) because: (1) Beneficiaries exist (early-adopter manufacturers, regulatory agencies) and receive real coordination benefits in addition to extraction rents; (2) Active enforcement mechanisms exist (regulatory approval frameworks, clinical training standardization, manufacturer ecosystem development); (3) The coordination function is non-trivial — safety validation of neural interfaces IS genuinely difficult and the first manufacturer investing in rigorous validation provides positive externality to competitors and patients (though they extract rents for this). The mandatrophy is NOT resolved by claiming the constraint is 'really just extraction' — the coordination is real. The mandatrophy IS resolved by showing that the constraint could be restructured to separate coordination from extraction: open standards could provide the safety validation and clinical training benefits while removing the lock-in extraction. The current tangled rope structure is not inevitable; it reflects policy choices (which manufacturer gets to set standards, which standards framework gets regulatory blessing) that concentrate extraction alongside coordination. The omega variables address whether biological complexity necessitates the current proprietary structure (suggesting mountain perspective applies) or whether standardization is feasible at the policy/engineering layer (suggesting snare+rope decomposition is more accurate than unified tangled rope). Until those empirical questions are resolved, mandatrophy stands: the constraint is tangled rope, but the proportions of coordination vs. extraction are not yet determined.
 */

/* ==========================================================================
   6. OMEGA VARIABLES (Ω) - IRREDUCIBLE UNCERTAINTIES
   ========================================================================== */

omega_variable(
    biocompatibility_variation_scope,
    'To what extent does genuine inter-individual neural tissue variation necessitate device-specific calibration vs. to what extent does manufacturer proprietary calibration create artificial incompatibility?',
    'Comparative analysis of open-standard calibration protocols vs proprietary protocols for the same neural interface hardware; cross-device validation studies; examination of neural signal characteristics across patient populations using standardized measurement conditions',
    'If variation is primarily biological: standardization is limited to data interchange formats and safety validation protocols, leaving manufacturers room for device differentiation (Rope perspective strengthened). If proprietary calibration is primary: genuine interoperability is feasible, and lock-in is pure rent extraction (Snare perspective strengthened, mountain perspective becomes false summit).',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(biocompatibility_variation_scope, empirical, 'Extent of true biocompatibility variation vs. artificial proprietary incompatibility').

omega_variable(
    regulatory_capture_reversibility,
    'Is the regulatory agency''s acceptance of incumbent standards reversible if genuine open standards become available, or has path dependence locked in the capture?',
    'Historical analysis of regulatory standard switching in analogous medical device domains (pacemakers, cochlear implants, insulin pumps); interviews with regulators about decision constraints; policy experiment: jurisdiction that adopts open neural interface standards and measures competitive entry impact',
    'If reversible: the constraint can transition from Snare+Tangled Rope to Rope+Scaffold as open standards mature (scaffold sunset becomes real). If locked in: regulatory capture is structural, and only external shock (litigation, political pressure) can break the path dependence.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(regulatory_capture_reversibility, empirical, 'Whether regulatory capture of neural interface standards is reversible').

omega_variable(
    network_effect_magnitude,
    'How large are the genuine network effects that make early-adopter standards attractive to downstream actors (software developers, clinicians, patients), and are these effects dependent on proprietary lock-in or achievable with open standards?',
    'Comparative case study: markets where open standards have achieved network effects (internet protocols, Linux ecosystem) vs. markets where lock-in has proven more durable (Apple/iOS, proprietary medical devices); modeling of switching costs vs. software ecosystem value for neural interfaces',
    'If network effects are lock-in-dependent: incumbent manufacturers must maintain proprietary control (snare structure persists). If open standards can achieve network effects: genuine coordination (rope) is possible without extraction.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(network_effect_magnitude, empirical, 'Magnitude and lock-in-dependency of network effects in neural interface ecosystem').

omega_variable(
    surgical_switching_cost_reduction,
    'Will emerging technologies (wireless power/data transfer, biodegradable scaffolds, implant-less interfaces) substantially reduce the surgical switching cost that currently traps patients?',
    'Technology roadmap analysis for next-generation neural interfaces; preclinical data on reversible implantation; cost projections for minimally invasive revision surgery',
    'If surgical switching becomes low-cost (< 10% of original implant cost): patient exit option shifts from ''trapped'' to ''constrained'', changing perspectives on tangled rope toward rope. Snare perspective becomes unsustainable. If surgical switching remains high-cost: patient trap persists regardless of standardization progress.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(surgical_switching_cost_reduction, empirical, 'Future reduction in surgical switching costs for neural interfaces').

omega_variable(
    false_summit_natural_law_test,
    'Is the claim that neural interface standardization is inherently difficult due to biological uniqueness (mountain perspective) actually a naturalization of a policy-and-engineering problem?',
    'Decomposition: (1) Identify which aspects of neural interfaces are biologically unique and necessitate individual calibration (genuine); (2) Identify which aspects operate at standardizable layers (data format, safety validation, firmware interface, software API); (3) Compare with historically analogous domains (pacemakers with individual patient variation, cochlear implants with auditory system uniqueness, EEG systems with individual brain electrical properties). Test whether standardization is feasible at the layers where it matters for switching costs.',
    'If biological uniqueness is limited to patient-level tuning parameters: standardization is feasible and lock-in is pure extraction (false summit confirmed, snare/tangled rope classification strengthened). If standardization is genuinely impossible: mountain perspective is correct, and lock-in is an inherent feature of neural interfaces rather than a policy failure.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(false_summit_natural_law_test, conceptual, 'Whether ''biological complexity'' naturalizes policy choices about standardization').


/* ==========================================================================
   7. INTEGRATION HOOKS
   ========================================================================== */

narrative_ontology:interval(neural_interface_standardization, 0, 10).

/* ==========================================================================
   8. TEMPORAL MEASUREMENTS (LIFECYCLE DRIFT DATA)
   ========================================================================== */

% Theater ratio over time
narrative_ontology:measurement(nis_tr_t0, neural_interface_standardization, theater_ratio, 0, 0.42).
narrative_ontology:measurement(nis_tr_t5, neural_interface_standardization, theater_ratio, 5, 0.5).
narrative_ontology:measurement(nis_tr_t10, neural_interface_standardization, theater_ratio, 10, 0.55).

% Extraction over time
narrative_ontology:measurement(nis_be_t0, neural_interface_standardization, base_extractiveness, 0, 0.35).
narrative_ontology:measurement(nis_be_t5, neural_interface_standardization, base_extractiveness, 5, 0.48).
narrative_ontology:measurement(nis_be_t10, neural_interface_standardization, base_extractiveness, 10, 0.58).

% Suppression requirement over time
narrative_ontology:measurement(nis_su_t0, neural_interface_standardization, suppression_requirement, 0, 0.5).
narrative_ontology:measurement(nis_su_t5, neural_interface_standardization, suppression_requirement, 5, 0.58).
narrative_ontology:measurement(nis_su_t10, neural_interface_standardization, suppression_requirement, 10, 0.62).


/* ==========================================================================
   9. BOLTZMANN & NETWORK DATA
   ========================================================================== */

narrative_ontology:coordination_type(neural_interface_standardization, enforcement_mechanism).
narrative_ontology:affects_constraint(neural_interface_standardization, neural_interface_firmware_lock_in).
narrative_ontology:affects_constraint(neural_interface_standardization, neural_interface_regulatory_approval).
narrative_ontology:affects_constraint(neural_interface_standardization, neural_interface_data_protocol_interoperability).

% DUAL FORMULATION NOTE:
% Neural interface standardization decomposes into three structurally distinct constraints: (1) firmware/software lock-in at the device-patient interface (ε≈0.65, Snare for patients, Rope for manufacturers) — drives patient switching costs; (2) regulatory approval standardization (ε≈0.48, Tangled Rope) — benefits incumbent manufacturers, creates barriers for competitors; (3) data protocol interoperability (ε≈0.35, Rope with coordination burden) — lower extraction but more technically tractable. This story integrates the family-level structure; the three siblings address the component mechanisms separately. The upstream story (regulatory approval standardization) influences the downstream stories (firmware lock-in and data protocol), because regulatory approval frameworks reference specific device technical specifications, making non-approved alternatives appear to clinicians as 'non-standard' even when equivalently safe.

/* ==========================================================================
   10. DIRECTIONALITY OVERRIDES (v6.0, OPTIONAL)
   ========================================================================== */

constraint_indexing:directionality_override(neural_interface_standardization, institutional, 0.35).

/* ==========================================================================
   END OF CONSTRAINT STORY
   ========================================================================== */
